Global airway management provider presents
innovative technology to address common challenges in clinical
practice
Innovative LMA® Products designed to give
physicians confidence to expand usage of laryngeal masks into
additional procedures
Teleflex Incorporated (NYSE:TFX), a leading global provider of
medical technologies for critical care and surgery, has a rich
history of innovation focused on solving unmet clinical needs.
Recent product introductions under the LMA® brand from Teleflex
focus on giving the physician enhanced control of the airway
throughout the use of anesthetic. Teleflex is scheduled to showcase
this innovative technology at the upcoming ANESTHESIOLOGY® 2016,
the annual organization meeting of the American Society of
Anesthesiologists® (ASA).
“Teleflex is proud of our heritage as an innovator in the field
of anesthesia,” said Justin McMurray, President of the Teleflex
Anesthesia & Emergency Medicine Division. “Our LMA brand
helped set the standard of care for airway management and we are
excited to continue this tradition with the introduction of new
technology and quality education that empower clinicians to achieve
airway control.”
Cuff Pressure Control:
Numerous scientific papers have highlighted the need to monitor
and control cuff pressures in laryngeal masks to reduce the risks
of patient trauma and airway leakage.1-3 Despite this evidence,
manometry is not routinely used to determine cuff pressure during
placement of a laryngeal mask or to monitor changes in cuff
pressure during a procedure.1,3,4 Instead, clinicians often judge
this by the 'feel' of the distension of the pilot valve.
The continuous control of intracuff pressure through in-line (or
integrated) cuff pressure monitoring has been clinically shown to
reduce the risk of patient trauma or leaks.4,5 Cuff Pilot™
Technology from Teleflex constantly monitors the pressure in the
cuff to detect changes resulting from fluctuations in temperature,
nitrous oxide levels and movements within the airway. This provides
clinicians with at-a-glance feedback, highlighting changes that
could affect patient safety. The pressure levels are color-coded to
indicate whether the cuff is at optimal pressure (green),
under-inflated (yellow) or over-inflated (red). Teleflex has made
Cuff Pilot™ Technology a standard feature on several single-use
LMA® Airway products, including the LMA® Protector™ Airway, LMA®
Unique™ (Silicone Cuff) Airway and the LMA® Gastro™ Airway.
Advanced Airway Control:
Establishing adequate controlled ventilation and avoiding air
leaks during anesthesia is of utmost concern to clinicians.6 Failed
ventilation can sabotage the anesthetic, impact patient safety with
consequent hypoventilation, increase risk of gastric inflation and
may add cost and complexity to procedures.6
The LMA® Protector™ Airway from Teleflex combines the latest
innovations in LMA® Airway design to help clinicians achieve
advanced airway control. The elongated silicone cuff is designed to
support seal pressures of >30 cm H20, enabling broad clinical
usage, while the distal tip facilitates a secure seal with the
upper esophageal sphincter to isolate the respiratory tract from
the digestive tract and help reduce the risk of aspiration of
gastric contents. This second-generation laryngeal mask has an
integrated drain tube that supports diagnostic testing to verify
mask positioning, and is equipped with Cuff Pilot™ Technology,
providing continuous cuff pressure monitoring throughout the
procedure.
The LMA® Protector™ Airway features a silicone airway tube with
a dynamic fixed curve, designed to enable rapid insertion and a
secure fit. In addition, it supports direct intubation under vision
for effective airway replacement. In the unlikely event of
regurgitation, the LMA® Protector™ Airway is equipped with a
proprietary dual gastric drainage channel and pharyngeal chamber
designed specifically to channel high-volume, high-pressure gastric
contents away from the airway.
Potential uses for the LMA® Protector™ Airway include:
- More difficult cases where an
endotracheal tube may otherwise be used, such as for patients with
controlled Gastroesophageal Reflux Disease (GERD)
- Cases for which Positive Pressure
Ventilation (PPV) may be required
Airway Control during Endoscopic Procedures
The use of moderate to deep sedation during endoscopy is a
common practice around the world. Respiratory depression from
sedative drugs and airway obstruction requiring intervention are
known risks associated with endoscopic procedures, with studies
demonstrating that hypoxemia can occur in 11–50% of cases.7-9 In
the United States there are more than 6.9 million upper endoscopies
performed per year.10 Today, many of these are undertaken without
an airway management device in place.
The new LMA® GastroTM Airway with Cuff Pilot™ Technology is the
only laryngeal mask specifically designed to help clinicians gain
control of a patient’s airway while facilitating direct endoscopic
access via the integrated endoscope channel. Indicated for airway
management in adult patients undergoing endoscopic procedures, the
LMA® Gastro™ Airway maintains a patent airway and allows clinicians
to monitor end tidal CO2, advancing patient safety during
endoscopic procedures. It also has an integral bite block to reduce
the potential for damage to the endoscope due to biting, helping to
avoid costly repairs.
Teleflex Academy
During the ANESTHESIOLOGY® 2016 annual meeting in Chicago,
Teleflex will offer in-booth education powered by ‘Teleflex
Academy’. Training will focus on a range of aspects of airway
control, inspiring confidence, enhancing skills and empowering
clinicians to advance anesthesia practice.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
American Society of Anesthesiologists, ASA, and ANESTHESIOLOGY
are trademarks or registered trademarks of American Society of
Anesthesiologists (ASA).
Teleflex, the Teleflex logo, Arrow, Cuff Pilot, Deknatel, Hudson
RCI, LMA, LMA Gastro, LMA Protector, LMA Unique, Pilling, Rusch and
Weck are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other
countries.
© 2016 Teleflex Incorporated. All rights reserved. MC-002748
References:
1. Bick E, Bailes I, Patel A, Brain AI. Fewer sore throats and a
better seal: why routine manometry for laryngeal mask airways must
become the standard of care. Anaesthesia.
2014;69(12):1304-1308.2.Burgard G, Mollhoff T, Prien T. The effect
of laryngeal mask cuff pressure on postoperative sore throat
incidence. J Clin Anesth. 1996;8(3):198-201.3.Seet E, Yousaf F,
Gupta S, Subramanyam R, Wong DT, Chung F. Use of manometry for
laryngeal mask airway reduces postoperative pharyngolaryngeal
adverse events: a prospective, randomized trial. Anesthesiology.
2010;112(3):652-657.4.Wong DT, Tam AD, Mehta V, Raveendran R, Riad
W, Chung FF. New supraglottic airway with built-in pressure
indicator decreases postoperative pharyngolaryngeal symptoms: a
randomized controlled trial. Can J Anaesth.
2013;60(12):1197-1203.5.Martin DP, Bhalla T, Thung A, Tobias JD.
Clinical evaluation of a novel LMA with a color-coded pressure
gauge. Int J Pediatr Otorhinolaryngol. 2013;77(1):76-78.6.Cook TM,
MacDougall-Davis SR. Complications and failure of airway
management. Br J Anaesth. 2012;109 Suppl 1:i68-i85.7.Cote GA, Hovis
RM, Ansstas MA, et al. Incidence of sedation-related complications
with propofol use during advanced endoscopic procedures. Clin
Gastroenterol Hepatol. 2010;8(2):137-142.8.Qadeer MA, Rocio Lopez
A, Dumot JA, Vargo JJ. Risk factors for hypoxemia during ambulatory
gastrointestinal endoscopy in ASA I-II patients. Dig Dis Sci.
2009;54(5):1035-1040.9.de Paulo GA, Martins FP, Macedo EP,
Goncalves ME, Mourao CA, Ferrari AP. Sedation in gastrointestinal
endoscopy: a prospective study comparing
nonanesthesiologist-administered propofol and monitored anesthesia
care. Endosc Int Open. 2015;3(1):E7-E13.10.Peery AF, Dellon ES,
Lund J, et al. Burden of gastrointestinal disease in the United
States: 2012 update. Gastroenterology. 2012;143(5):1179-1187
e1-3.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161019005023/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024